This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Euclid Diagnostics LLC. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Deborah Nusskern
Introduction
Deborah Nusskern is a notable inventor based in Forest Park, IL (US). She has made significant contributions to the field of cancer diagnostics through her innovative work. With a focus on evaluating cancer, particularly prostate cancer, her inventions have the potential to impact patient care and treatment outcomes.
Latest Patents
Deborah Nusskern holds 1 patent for her invention titled "Materials and method for assaying for methylation of CpG islands associated with genes in the evaluation of cancer." This patent provides methods, reagents, and kits for evaluating cancer in a subject. The disclosed methods include diagnosing cancer, prognosticating cancer, and assessing the efficacy of cancer treatment. Her innovative approach involves assaying a biological sample for methylation of a CpG island associated with specified genes, which is crucial for accurate cancer evaluation.
Career Highlights
Throughout her career, Deborah has demonstrated a commitment to advancing cancer research and diagnostics. Her work at Euclid Diagnostics LLC showcases her dedication to developing effective tools for cancer evaluation. The impact of her inventions is evident in the potential they hold for improving patient outcomes.
Collaborations
Deborah collaborates with Wadiha Freije, who is also a key contributor in their field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in cancer diagnostics.
Conclusion
Deborah Nusskern's contributions to cancer diagnostics through her innovative patent highlight her role as a significant inventor in the field. Her work not only advances scientific understanding but also has the potential to improve the lives of patients facing cancer.